Cargando…

Prostate-Specific Antigen and Testosterone Levels as Biochemical Indicators of Cognitive Function in Prostate Cancer Survivors and the Role of Diabetes

Prostate cancer (PC) is one of the most common malignancies in men. The increase in the number of PC survivors is associated with many problems including cognitive impairment. Early detection of such problems facilitates timely protective intervention. This study examined the association between pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Popiołek, Alicja, Brzoszczyk, Bartosz, Jarzemski, Piotr, Chyrek-Tomaszewska, Aleksandra, Wieczór, Radosław, Borkowska, Alina, Bieliński, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619514/ https://www.ncbi.nlm.nih.gov/pubmed/34830590 http://dx.doi.org/10.3390/jcm10225307

Ejemplares similares

Quality of Life of Prostate Cancer Patients Undergoing Prostatectomy and Affective Temperament
por: Popiołek, Alicja, et al.
Publicado: (2022)

Biochemical Parameters in Cognitive Functions
por: Popiołek, Alicja Katarzyna, et al.
Publicado: (2020)

Cognitive function, depression, and anxiety in patients undergoing radical prostatectomy with and without adjuvant treatment
por: Jarzemski, Piotr, et al.
Publicado: (2019)

Affective temperament in inflammatory bowel diseases: Another brick in the wall of differentiation
por: Bieliński, Maciej, et al.
Publicado: (2018)

Simultaneous bilateral native nephrectomy by retroperitoneal approach
por: Jarzemski, Piotr, et al.
Publicado: (2020)

Laparoscopic radical prostatectomy and extended pelvic lymph node dissection: a combined technique
por: Jarzemski, Piotr, et al.
Publicado: (2020)

Urology resident training in laparoscopic surgery – results of the first national survey in Poland
por: Brzoszczyk, Bartosz, et al.
Publicado: (2019)

Recent Research Advances in Double-Strand Break and Mismatch Repair Defects in Prostate Cancer and Potential Clinical Applications
por: Jaworski, Damian, et al.
Publicado: (2023)

Combined tests of prostate specific antigen and testosterone will improve diagnosis and monitoring the progression of prostate cancer
por: Song, Weitao, et al.
Publicado: (2015)

Randomized-Controlled Trial Examining the Effect of Pelvic Floor Muscle Training in the Treatment of Stress Urinary Incontinence in Men after a Laparoscopic Radical Prostatectomy Pilot Study
por: Strojek, Katarzyna, et al.
Publicado: (2021)

Testosterone replacement and prostate cancer
por: Ramasamy, Ranjith, et al.
Publicado: (2012)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Testosterone therapy and prostate cancer
por: Pastuszak, Alexander W., et al.
Publicado: (2016)

Prostate specific antigen and relative prostate weight data on effect of Tetracarpidium conophorum leaf extract on testosterone-induced benign prostatic hyperplasia
por: Omotosho, Omolola E., et al.
Publicado: (2018)

Serum testosterone and prostate-specific antigen levels are major risk factors for prostatic volume increase among benign prostatic hyperplasia patients
por: Kusuma Duarsa, Gede Wirya, et al.
Publicado: (2021)

Neurochemical Changes in the Brain and Neuropsychiatric Symptoms in Clinically Isolated Syndrome
por: Guenter, Wojciech, et al.
Publicado: (2020)

Prostate-Specific Antigen Concentrations in Response to Testosterone Treatment of Severely Hypogonadal Men
por: Sachdev, Saachi, et al.
Publicado: (2020)

Association between COMT Val158Met and DAT1 polymorphisms and depressive symptoms in the obese population
por: Bieliński, Maciej, et al.
Publicado: (2017)

Serum Testosterone Level, Testosterone Replacement Treatment, and Prostate Cancer
por: Atan, Ali, et al.
Publicado: (2013)

Serum testosterone and dihydrotestosterone in carcinoma of the prostate.
por: Ghanadian, R., et al.
Publicado: (1979)

Testosterone Therapy in Advanced Prostate Cancer
por: Chedrawe, Emily, et al.
Publicado: (2022)

Do prostate-specific antigen parameters have a similar role in predicting prostate cancer regardless of serum testosterone levels in men with gray-zone prostate-specific antigen levels?
por: Oh, Jeong Hoon, et al.
Publicado: (2022)

SUN-223 Impact of Testosterone Replacement Therapy (TRT) on Prostate Specific Antigen (PSA) in Patients with Clinical Evidence of Prostate Hyperplasia
por: Subramaniam, Shreya, et al.
Publicado: (2019)

Circulating testosterone and prostate-specific antigen in nipple aspirate fluid and tissue are associated with breast cancer.
por: Sauter, Edward R, et al.
Publicado: (2002)

Is There an Association Between Serum Prostate-Specific Antigen Values and Serum Testosterone Levels in Healthy Men?
por: Mustafa, Mahmoud, et al.
Publicado: (2014)

Significance of Serum Testosterone for Prostate-Specific Antigen (PSA) Elevation and Prediction of Prostate Cancer in Patients with PSA Above 10 ng/ml
por: Koo, Jin Mo, et al.
Publicado: (2010)

Correlation Between Serum Prostate-Specific Antigen and Testosterone Following Bilateral Total Orchidectomy for Patients with Advanced Prostate Cancer in Jos, Nigeria
por: Osunaiye, Olutayo Israel, et al.
Publicado: (2023)

Clinical Significance of Gene Mutations and Polymorphic Variants and their Association with Prostate Cancer Risk in Polish Men
por: Heise, Marta, et al.
Publicado: (2022)

AB007. Testosterone and radiotherapy for prostate cancer
por: Incrocci, Luca
Publicado: (2015)

Testosterone Replacement Therapy and Prostate Cancer Incidence
por: Eisenberg, Michael Louis
Publicado: (2015)

Testosterone replacement therapy and the risk of prostate cancer
por: Warburton, Daniel, et al.
Publicado: (2015)

Relationship between endogenous testosterone and prostate carcinoma
por: Paunikar, Vaishali M., et al.
Publicado: (2022)

Testosterone treatment and the risk of aggressive prostate cancer in men with low testosterone levels
por: Walsh, Thomas J., et al.
Publicado: (2018)

Endogenous testosterone density as ratio of endogenous testosterone levels on prostate volume predicts tumor upgrading in low-risk prostate cancer
por: Porcaro, Antonio Benito, et al.
Publicado: (2021)

Distinguishing prostate-specific antigen bounces from biochemical failure after low-dose-rate prostate brachytherapy
por: Hackett, Cian, et al.
Publicado: (2014)

Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer
por: Kang, Ho Won, et al.
Publicado: (2016)

Comparison of the Effects of Testosterone Gels, Injections, and Pellets on Serum Hormones, Erythrocytosis, Lipids, and Prostate-Specific Antigen
por: Pastuszak, Alexander W, et al.
Publicado: (2015)

Effect of serum testosterone and percent tumor volume on extra-prostatic extension and biochemical recurrence after laparoscopic radical prostatectomy
por: Hwang, Eu Chang, et al.
Publicado: (2016)

A prospective study of the effect of testosterone escape on preradiotherapy prostate-specific antigen kinetics in prostate cancer patients undergoing neoadjuvant androgen deprivation therapy
por: Christie, David R.H., et al.
Publicado: (2021)

Morphological Responses of Prostatic Carcinoma to Testosterone in Organ Culture
por: McMahon, M. J., et al.
Publicado: (1972)

Cannot write session to /tmp/vufind_sessions/sess_phopbqr2tghgr713mp3l5beq03